Page 20 - Emergent Biosolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kamala Harris marks 100th day in office by visiting Baltimore vaccination site Vice President Kamala Harris speaks at a vaccination site at M&T Bank Stadium on Thursday. (Jacquelyn Martin / Associated Press) Print Vice President Kamala Harris visited Baltimore on Thursday to mark the 100th day of the Biden-Harris administration with a tour of the mass COVID-19 vaccination site at M&T Bank Stadium. Harris arrived via helicopter shortly after 1:30 p.m. in Port Covington, then took a short drive to the stadium site, where Republican Gov. Larry Hogan, Democratic Mayor Brandon Scott and Dr...

Share this article NEW YORK, April 29, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between July 6, 2020 through March 31, 2021, inclusive (the "Class Period") of the important June 18, 2021 lead plaintiff deadline. SO WHAT: If you purchased Emergent BioSolutions securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Emergent BioSolutions class act...

'); b.push("");for(var c=0;c "),b.push(a[c]),b.push(""+"script".toString()+">");b.push("");b.push("

Share this article NEW YORK, April 24, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between July 6, 2020 through March 31, 2021, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 18, 2021. SO WHAT: If you purchased Emergent BioSolutions securities during the Class Period you may be entitled to compensation without paymen...

NEW YORK, April 24, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between July 6, 2020 through March 31, 2021, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 18, 2021. - Advertisement - SO WHAT: If you purchased Emergent BioSolutions securities during the Class Period you may be entitled to compensation without payme...